Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3433256
Title:
DERIVE DE 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLEINE UTILE DANS LE TRAITEMENT DU CANCER
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
177838570
WO application number:
EP2017076191
Type:
European patent granted for BE
Status:
Open
Publication number:
3433256
WO publication number:
WO2018077630
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
13/10/2017
Grant date:
07/08/2019
EP publication date:
30/01/2019
WO publication date:
03/05/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
07/08/2019
EP B1 publication date:
07/08/2019
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
13/10/2037
Applicant
Name:
Astrazeneca AB
Legal Form:
From:
07/08/2019
Address:
151 85 Södertälje, Sweden (SE)
To:
Agent
1
Name:
AWA Benelux SA
Legal Form:
From:
27/02/2023
Address:
Tour & Taxis - Royal Depot box: 216
Avenue du Port 86c, 1000, BRUXELLES, Belgium (BE)
To:
2
Name:
AWA Benelux SA
Legal Form:
From:
08/10/2019
Address:
Tour & Taxis - Royal Depot box: 216
Avenue du Port 86c, 1000, BRUXELLES, Belgium (BE)
To:
27/02/2023
Inventor
1
Name:
SCOTT, James, Stewart
Legal Form:
Address:
Cambridge
Cambridgeshire CB4 0WG, United Kingdom (GB)
2
Name:
BARLAAM, Bernard, Christophe
Legal Form:
Address:
Cambridge
Cambridgeshire CB4 0WG, United Kingdom (GB)
3
Name:
YANG, Bin
Legal Form:
Address:
Waltham, MA 02451, United States (US)
4
Name:
MOSS, Thomas, Andrew
Legal Form:
Address:
Cambridge
Cambridgeshire CB4 0WG, United Kingdom (GB)
5
Name:
HUGHES, Samantha, Jayne
Legal Form:
Address:
Cambridge
Cambridgeshire CB4 0WG, United Kingdom (GB)
6
Name:
NISSINK, Johannes, Wilhelmus, Maria
Legal Form:
Address:
Cambridge
Canbridgeshire CB4 0WG, United Kingdom (GB)
7
Name:
O'DONOVAN, Daniel, Hillebrand
Legal Form:
Address:
Cambridge
Cambridgeshire CB4 0WG, United Kingdom (GB)